While tumor cells have developed mechanisms to overcome lipotoxicity and peroxidation [47], these studies reveal that intratumoral CD8 T cells are sensitive to ferroptosis and that GPX4 may be a novel target for CD8 T cell-based therapies. The gene discussed is CD8A; the disease is neoplasm.